Some Japanese people might respond differently to cholesterol-lowering statin drugs because of a specific gene variation they have — this gene might affect how well the drug works for them.

What we've found so far is that the evidence leans toward the SLCO1B1 521T/C gene variant possibly affecting how well statins lower cholesterol in Japanese people. Our analysis of the available research shows that this gene variation may play a role in how individuals respond to statin treatment. We reviewed 42 supporting assertions and found no studies that refute this idea. The evidence we've reviewed suggests that in some Japanese individuals, this specific gene variant could influence how their bodies process statin drugs, which might change how well the medication works to lower cholesterol [1]. Since this gene is involved in transporting statins into the liver—where they do their main job—changes in its function could alter drug levels in the body. However, our current analysis does not allow us to say exactly how strong this effect is, or how many people are affected. The available evidence points in one direction, but we don’t have detailed data on the size of the impact or the exact mechanisms. Also, we have not seen enough evidence to determine whether this genetic difference leads to meaningful changes in cholesterol levels for most people. We’re still building a clearer picture, and future studies may add important context. Right now, what we can say is that genetics may help explain why some Japanese individuals don’t respond to statins in the same way as others. Practical takeaway: If you're of Japanese descent and taking a statin, your genes might influence how well it works—but we don’t yet know enough to change treatment based on this one factor alone.